The emerging role of noncoding RNAs in the EGFR signaling pathway in lung cancer
Noncoding ribonucleic acids (ncRNAs) have surfaced as essential orchestrators within the
intricate system of neoplastic biology. Specifically, the epidermal growth factor receptor …
intricate system of neoplastic biology. Specifically, the epidermal growth factor receptor …
Identifying genes associated with resistance to KRAS G12C inhibitors via machine learning methods
X Lin, QL Ma, L Chen, W Guo, Z Huang… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Background Targeted therapy has revolutionized cancer treatment, greatly improving patient
outcomes and quality of life. Lung cancer, specifically non-small cell lung cancer, is …
outcomes and quality of life. Lung cancer, specifically non-small cell lung cancer, is …
[HTML][HTML] Advances in prognostic models for osteosarcoma risk
Y Yao, D Wang, L Zheng, J Zhao, M Tan - Heliyon, 2024 - cell.com
The risk prognosis model is a statistical model that uses a set of features to predict whether
an individual will develop a specific disease or clinical outcome. It can be used in clinical …
an individual will develop a specific disease or clinical outcome. It can be used in clinical …
[HTML][HTML] Downregulation of PTPRT elevates the expression of survivin and promotes the proliferation, migration, and invasion of lung adenocarcinoma
C Chen, H Liu, Y Li, Q Xu, J Liu - BMC cancer, 2024 - Springer
Background Receptor-type tyrosine-protein phosphatase T (PTPRT) is a transmembrane
protein that is involved in cell adhesion. We previously found that PTPRT was …
protein that is involved in cell adhesion. We previously found that PTPRT was …
[HTML][HTML] Identification of a 16-MTGs Prognostic Signature in Diffuse large B-cell lymphoma
S Wang, X Wang, G Li, P Feng - Analytical Cellular Pathology, 2022 - hindawi.com
Background. Diffuse large B-cell lymphoma (DLBCL) is one of the largest lymphoma
subcategories. Usually, 50%–70% of DLBCL patients can be cured by the standard …
subcategories. Usually, 50%–70% of DLBCL patients can be cured by the standard …
The role of KMT5C on EGFR inhibitor resistance in non-small cell lung cancer
AA Montealegre - 2023 - search.proquest.com
Lung cancer is the leading cause of cancer-related deaths, and although important therapy
advancements have been achieved,~ 1.6 million people die from lung cancer annually. Non …
advancements have been achieved,~ 1.6 million people die from lung cancer annually. Non …